The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Time to biochemical and radiographic progression in patients treated with adenovirus-PSA vaccine for non-metastatic/early metastatic castrate-resistant prostate cancer: Phase 2 trial results.
 
Daniel A. Vaena
Consulting or Advisory Role - Bayer
Research Funding - Altor BioScience (Inst); Argos Therapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Tekmira (Inst); Threshold Pharmaceuticals (Inst)
 
Kenneth Gerard Nepple
No Relationships to Disclose
 
James A. Brown
No Relationships to Disclose
 
Karen Griffith
No Relationships to Disclose
 
Pamela Zehr
Stock and Other Ownership Interests - Argos Therapeutics; Newlink Genetics
 
David Lubaroff
Patents, Royalties, Other Intellectual Property - University of Iowa (Inst)